bioRxivPathologyPreprint
X-SPATIO: An Explanatory Deep Learning Pipeline for the Prediction and Visualization of Spatially Resolved Biomarker Expression in Triple-Negative Breast Cancer
V. Madhusudhan Rao, Madhumala K. SadanandappaiD, Candice C. BlackiD, Scott M. Palisoul, Adrienne A. WorkmaniD, Todd A. MacKenzieiD, Xiaoying LiuiD, Mary Dickinson ChamberliniD, Louis Joseph VaickusiD, George J. ZanazziiD, Shrey SukhadiaiD
Abstract
Histopathologic evaluation remains central to cancer diagnosis and treatment planning, yet the molecular programs underlying distinct tissue morphologies are not routinely accessible in clinical workflows. Spatial transcriptomic/proteomic platforms provide region-specific molecular measurements but are limited by cost, throughput, and scalability. Most computational pathology models rely on either bulk tissue-based gene expression or a focused gene/protein expression-panel prediction, thereby obscuring subregion-specific morpho-molecular relationships and limiting spatial interpretation of a wider gene/protein expression network. This limitation is particularly significant in triple-negative breast cancer (TNBC), which exhibits pronounced spatial heterogeneity across tumor, stroma, and immune compartments. We developed X-SPATIO, a spatially compatible computational pipeline designed to directly link hematoxylin and eosin (H&E) morphology with region-matched mRNA and protein expression. The model was trained on H&E-defined regions of interest paired with spatially-resolved transcriptomic and proteomic data obtained from GeoMx Digital Spatial Profiler. Using a multiple-instance learning approach, X-SPATIO captures morpho-molecular associations, generating spatio-morphologic attention maps that indicate predictive tissue regions. X-SPATIO demonstrated strong performance across biologically relevant spatial biomarkers, achieving area under the curve values ranging [0.79, 0.97]. Attention maps revealed spatial patterns consistent with known biology, indicating alignment between learned features and tissue organization. By integrating spatial molecular ground truth with routine histopathology, X-SPATIO enables cost-effective inference of spatial biomarker expression and establishes a foundation for biologically grounded discovery and precision oncology in TNBC.
- organism: human
- assay: spatial transcriptomics
- assay: proteomics
- research focus: cell-cell communication
- research focus: spatial domain detection
- approach: deep learning
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Efficient prediction of a spatial transcriptomics profile better characterizes breast cancer tissue sections without costly experimentation
Taku Monjo, Masaru Koido, … Yoichiro Kamatani·Scientific ReportsPeer-reviewed·Mar 8, 2022
- AI-Driven Spatial Transcriptomics Unlocks Large-Scale Breast Cancer Biomarker Discovery from Histopathology
Eldad David Shulman, Emma M. Campagnolo, … Eytan Ruppin·CellPeer-reviewed·May 8, 2026
- Integrating cellular graph embeddings with tumor morphological features to predict in-silico spatial transcriptomics from H&E images
K. Liu, V. Prabhakar·bioRxiv·Oct 31, 2023
- Spatial and Compositional Biomarkers in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast Cancer
Haoyang Mi, Ravi Varadhan, … Aleksander S. Popel·bioRxiv·Dec 18, 2023
- Spatially distinct cellular and molecular landscapes define prognosis in triple negative breast cancer
Kavitha Mukund, Darya Veraksa, … Shankar Subramaniam·Cell ReportsPeer-reviewed·Dec 31, 2025
- Identifying tissue states by spatial protein patterns related to chemotherapy response in triple-negative breast cancer
Luciana Melina Luque, Asif Khan, … Linus J. Schumacher·bioRxiv·Oct 6, 2025